| P2093 | author name string | Herman Vromans | |
| | Fried Faassen | |
| P2860 | cites work | A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability | Q28293773 |
| | P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 |
| | In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs | Q34061188 |
| | Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract | Q34190317 |
| | Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate | Q34347138 |
| | Bioavailability and bioequivalence: an FDA regulatory overview | Q34489341 |
| | Examination of the solubilization of drugs by bile salt micelles | Q34736775 |
| | Clinical pharmacokinetics of ketoprofen and its enantiomers | Q37950598 |
| | Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media | Q40648419 |
| | Clinical pharmacokinetics of naproxen | Q41440092 |
| | A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. | Q43632762 |
| | Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans | Q43710900 |
| | Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs | Q44572393 |
| | Nonlinear plasma level response to high doses of naproxen | Q47886452 |
| | Stereoselective pharmacokinetics and inversion of (R)- ketoprofen in healthy volunteers. | Q50895318 |
| | Pharmacokinetics and dose proportionality of domperidone in healthy volunteers. | Q51632090 |
| | Influence of passive permeability on apparent P-glycoprotein kinetics. | Q52065825 |
| | Pharmacokinetics of naproxen overdoses | Q67785426 |
| | Solubilization and wetting effects of bile salts on the dissolution of steroids | Q67882536 |
| | On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration | Q70825479 |
| | Physicochemical properties and transport of steroids across Caco-2 cells | Q73124675 |
| | Biopharmaceutics classification system: the scientific basis for biowaiver extensions | Q74614652 |
| | Jejunal absorption and metabolism of R/S-verapamil in humans | Q74731555 |
| | Safety, tolerability, and pharmacokinetics of a novel, selective antiprogestagen (Org 31710) in healthy male volunteers | Q77320734 |
| P433 | issue | 15 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1117-1126 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Biowaivers for oral immediate-release products: implications of linear pharmacokinetics | |
| P478 | volume | 43 | |